Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geer

Showing results (1021-1030 of 1,197) with videos related to

Pageof 120
Sort By:
Hormones (Athens, Greece)|August 6, 2025
EndoBridge 2024: pearls and highlightsBulent Okan Yildiz, Eleni Armeni, Chrysanthi Balodimou, et al.
Nature Genetics|June 26, 2012
Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CAMarjorie J Lindhurst, Victoria E R Parker, Felicity Payne, et al.
Nucleic Acids Research|January 10, 2003
CDD: a curated Entrez database of conserved domain alignmentsAron Marchler-Bauer, John B Anderson, Carol DeWeese-Scott, et al.
Nucleic Acids Research|December 16, 2006
Database resources of the National Center for Biotechnology InformationDavid L Wheeler, Tanya Barrett, Dennis A Benson, et al.
NPJ Primary Care Respiratory Medicine|May 26, 2022
Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalersJanwillem W H Kocks, Hans Wouters, Sinthia Bosnic-Anticevich, et al.
Nucleic Acids Research|January 10, 2003
MMDB: Entrez's 3D-structure databaseJie Chen, John B Anderson, Carol DeWeese-Scott, et al.
Nucleic Acids Research|November 30, 2007
Database resources of the National Center for Biotechnology InformationDavid L Wheeler, Tanya Barrett, Dennis A Benson, et al.
The Lancet. Haematology|November 3, 2022
Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trialHartmut Goldschmidt, Elias K Mai, Uta Bertsch, et al.
Nucleic Acids Research|October 23, 2008
Database resources of the National Center for Biotechnology InformationEric W Sayers, Tanya Barrett, Dennis A Benson, et al.
Trials|November 4, 2021
Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AMLSonia Jaramillo, Johannes Krisam, Lucian Le Cornet, et al.
Pageof 120

Showing results (1021-1030 of 1,197) with videos related to

Sort By:
Pageof 120
Hormones (Athens, Greece)|August 6, 2025
EndoBridge 2024: pearls and highlightsBulent Okan Yildiz, Eleni Armeni, Chrysanthi Balodimou, et al.
Nature Genetics|June 26, 2012
Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CAMarjorie J Lindhurst, Victoria E R Parker, Felicity Payne, et al.
Nucleic Acids Research|January 10, 2003
CDD: a curated Entrez database of conserved domain alignmentsAron Marchler-Bauer, John B Anderson, Carol DeWeese-Scott, et al.
Nucleic Acids Research|December 16, 2006
Database resources of the National Center for Biotechnology InformationDavid L Wheeler, Tanya Barrett, Dennis A Benson, et al.
NPJ Primary Care Respiratory Medicine|May 26, 2022
Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalersJanwillem W H Kocks, Hans Wouters, Sinthia Bosnic-Anticevich, et al.
Nucleic Acids Research|January 10, 2003
MMDB: Entrez's 3D-structure databaseJie Chen, John B Anderson, Carol DeWeese-Scott, et al.
Nucleic Acids Research|November 30, 2007
Database resources of the National Center for Biotechnology InformationDavid L Wheeler, Tanya Barrett, Dennis A Benson, et al.
The Lancet. Haematology|November 3, 2022
Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trialHartmut Goldschmidt, Elias K Mai, Uta Bertsch, et al.
Nucleic Acids Research|October 23, 2008
Database resources of the National Center for Biotechnology InformationEric W Sayers, Tanya Barrett, Dennis A Benson, et al.
Trials|November 4, 2021
Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AMLSonia Jaramillo, Johannes Krisam, Lucian Le Cornet, et al.
Pageof 120